Page last updated: 2024-09-03

mozavaptan and senktide

mozavaptan has been researched along with senktide in 1 studies

Compound Research Comparison

Studies
(mozavaptan)
Trials
(mozavaptan)
Recent Studies (post-2010)
(mozavaptan)
Studies
(senktide)
Trials
(senktide)
Recent Studies (post-2010) (senktide)
165824292150

Protein Interaction Comparison

ProteinTaxonomymozavaptan (IC50)senktide (IC50)
Neuromedin-K receptorRattus norvegicus (Norway rat)0.011
Neuromedin-K receptorHomo sapiens (human)0.0263
Neuromedin-K receptorCavia porcellus (domestic guinea pig)0.012

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kamiya, H; Matsumoto, T; Nakayama, Y; Saigo, A; Saito, R; Takano, Y; Tran, M; Yamada, K1

Other Studies

1 other study(ies) available for mozavaptan and senktide

ArticleYear
Central administration of senktide, a tachykinin NK-3 agonist, has an antidiuretic action by stimulating AVP release in water-loaded rats.
    Neuroscience letters, 1993, Sep-03, Volume: 159, Issue:1-2

    Topics: Animals; Arginine Vasopressin; Benzazepines; Diuresis; Injections, Intraventricular; Male; Peptide Fragments; Rats; Rats, Wistar; Receptors, Neurokinin-3; Substance P; Urodynamics; Water

1993